SCHEMBL8304732

SCHEMBL8304732

NCC(=O)Nn1cccc1C(=O)c1cccc(F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.42
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38
KAT6A Q92794 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
ALDH1A1 P00352 1/20 0.38
PLA2G7 Q13093 1/20 0.37
KDM4E B2RXH2 1/20 0.36
NPC1 O15118 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8304091 0.93 KAT6A (0.39) PARP1CES2CES1HDAC1HDAC6
Fumaric Acid SCHEMBL8304095 0.93 KAT6A (0.39) PARP1CES2CES1HDAC1HDAC6
SCHEMBL10909763 0.84 RECQL (0.49) CYP2D6CYP2C9CYP2C19MEN1KMT2A
Bromide SCHEMBL10365710 0.82 RECQL (0.48) CYP2D6CYP2C9CYP2C19MEN1KMT2A
Hydrochloric Acid SCHEMBL10366206 0.82 RECQL (0.48) CYP2D6CYP2C9CYP2C19MEN1KMT2A
SCHEMBL8303462 0.76 CES2 (0.38) CES2CES1GAAKAT6AMEN1
Bromide SCHEMBL8305746 0.75 CES2 (0.37) CES2CES1GAAKAT6AMEN1
Bromide SCHEMBL10365922 0.75 CES2 (0.37) CES2CES1GAAKAT6AMEN1
Bromide SCHEMBL8305743 0.75 CES2 (0.37) CES2CES1GAAKAT6AMEN1
SCHEMBL8304094 0.75 PARP1 (0.35) PARP1CES2CES1HDAC1HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0582182-B1 1-Aminoacetamidopyrroles and 1-amino-2-(substituted) pyrroles and their use for the treatment of neurodegenerative dysfunctions HOECHST MARION ROUSSEL INC (US) 1999-10-20 EP claimed